Detalhe da pesquisa
1.
Is pre-diabetes a predictor of events in patients with atrial fibrillation?
Int J Cardiol
; 407: 132086, 2024 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648915
2.
Liver fibrosis and outcomes of atrial fibrillation: the FIB-4 index.
Clin Res Cardiol
; 113(2): 313-323, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010520
3.
Bleeding and embolic risk in patients with atrial fibrillation and cancer.
Rev Esp Cardiol (Engl Ed)
; 76(5): 344-352, 2023 May.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36321538
4.
Predictive value of bleeding risk scores in elderly patients with atrial fibrillation and oral anticoagulation.
J Geriatr Cardiol
; 20(9): 684-692, 2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840634
5.
Effect of mitral regurgitation on stroke risk in patients with non-rheumatic atrial fibrillation.
Arch Cardiovasc Dis
; 115(8-9): 448-456, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030169
6.
Validation of Embolic and Bleeding Risk Scores in Patients With Atrial Fibrillation and Cancer.
Am J Cardiol
; 180: 44-51, 2022 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35914971
7.
Comparison of Outcomes in Patients With Atrial Fibrillation Under Oral Anticoagulation Therapy Analyzed by Body Weight (<60, 60 to 100, and >100 kg).
Am J Cardiol
; 184: 41-47, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36175253
8.
Suboptimal anticoagulation with vitamin K antagonists: the need to change the national therapeutic positioning report.
Rev Esp Cardiol (Engl Ed)
; 76(3): 197-198, 2023 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36075567
9.
Riesgo hemorrágico y embólico de los pacientes con fibrilación auricular y cáncer / Bleeding and embolic risk in patients with atrial fibrillation and cancer
Rev. esp. cardiol. (Ed. impr.)
; 76(5): 344-352, mayo 2023. graf, tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-219662
10.
Anticoagulación subóptima con antagonistas de la vitamina K: es necesario cambiar el informe de posicionamiento terapéutico nacional / Suboptimal anticoagulation with vitamin K antagonists: the need to change the national therapeutic positioning report
Rev. esp. cardiol. (Ed. impr.)
; 76(3): 197-198, mar, 2023. graf
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-216569